Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China.

Details

Language :

English

ISSN :

15254135

Volume :

91

Database :

Complementary Index

Journal :

JAIDS: Journal of Acquired Immune Deficiency Syndromes

Publication Type :

Academic Journal

Accession number :

159061700

Full Text :

https://doi.org/10.1097/QAI.0000000000003040